Surrogacy in Hong Kong: legal framework, commercial prohibition and non-commercial limits
The legal answer in context
Hong Kong does not impose a blanket prohibition on every surrogacy arrangement. It prohibits commercial surrogacy-related arranging, brokering and advertising, while allowing a narrowly defined non-commercial reproductive-technology route under strict statutory and licensing conditions. That distinction is more limited than saying “altruistic surrogacy is legal”: permission in principle does not establish that any particular couple, surrogate or clinic may proceed. The government states that the policy is neither actively to encourage nor categorically oppose surrogacy. It intends to safeguard the child and prevent exploitation. A further barrier is practical: the Hong Kong Inland Revenue Department currently states that no licensed local centre is authorised to provide surrogacy arrangements. Accordingly, a reader should separate five questions: what acts are prohibited; which medical conditions apply; whether an authorised centre exists; whether a contract can be enforced; and how legal parenthood could later be established.
What the law regulates
The primary Hong Kong legislation is the Human Reproductive Technology Ordinance (Cap. 561), particularly sections 2, 13–18 and 39. Reproductive procedures and the handling of gametes and embryos are regulated through licences issued by the Council on Human Reproductive Technology (CHRT). The Council’s Code of Practice gives operational conditions for providers, including its Chapter XII on surrogacy. The Parent and Child Ordinance (Cap. 429), especially sections 9, 10 and 12, governs the separate question of who is treated as a parent. A government policy answer or clinic policy is not an amendment to legislation. Hong Kong is a distinct jurisdiction within the PRC: a programme offered in Mainland China, another country or an overseas clinic is not automatically authorised or recognised in Hong Kong.
For these rules, a surrogate arrangement concerns a woman who, under an arrangement made before the pregnancy, carries a child conceived through a reproductive-technology procedure with a view to the child being handed over and parental responsibility exercised by others. It should not be confused with ordinary pregnancy, informal adoption or a purely private promise without the defined treatment facts. A plan must therefore identify the embryo, whose sperm and egg are used, the marital relationship, who performs the procedure, where every step takes place, and what payment or publicity accompanies it. The definition of a surrogacy arrangement, the statutory rules for treating infertility and the later tests for a parental order are not interchangeable. Even a potentially valid parental order after birth does not retrospectively licence an unauthorised medical procedure.
Commercial arrangements and payments
Section 17 of Cap. 561 prohibits making or receiving payment, whether in Hong Kong or elsewhere, for initiating or participating in negotiations to make a surrogacy arrangement, offering or agreeing to negotiate one, or assembling information for that purpose. It also reaches finding persons willing to carry out prohibited brokerage, managing an organisation carrying out those acts and furthering an arrangement where the person knows, or ought reasonably to know, that it is affected by such prohibited paid conduct. The section expressly addresses intermediary activities; calling an intermediary a “consultant”, a “donation coordinator” or a foreign company does not answer whether its actual paid work falls within the prohibited acts. Payment can be money or something of value. Contract labels, payment routing, citizenship and the place of an invoice are not reliable substitutes for assessing what was actually done.
Section 17(2) separately restricts causing, knowingly publishing or distributing advertising relating to surrogacy arrangements; the statutory wording is not limited to advertisements that state a commercial fee. Publishing an offer to recruit a surrogate or promote matching requires particular legal scrutiny. Section 16 also prohibits specified commercial dealings in gametes and embryos. An advertisement, paid matching service and transfer of embryos can engage different rules at once. Because section 17 uses “whether in Hong Kong or elsewhere” for certain paid conduct, an overseas agency cannot safely assume that doing the work abroad removes all Hong Kong legal exposure. The precise persons, conduct, territorial nexus and enforcement questions require individual analysis; this article does not assert that every overseas surrogacy programme is a Hong Kong offence.
The statutory definition of “payment” in section 2 excludes certain genuine cost reimbursements. In a surrogacy context it identifies expenses of reproductive-technology procedures for the surrogate and bona fide medical expenses arising from pregnancy and childbirth. That is a narrow exclusion, not a general licence to pay a salary, success fee, bonus, flat-rate “compensation”, matching commission or every claimed lost earning. Separate expenses connected with supplying gametes have their own wording; they should not automatically be transferred to the surrogate-mother category. Record real invoices and beneficiaries. Section 12(7) of Cap. 429 sets a different parental-order test concerning reasonably incurred expenses or court authorisation. Approval of payments in a parental-order case should not be misrepresented as immunity from criminal provisions of Cap. 561. In LH v LW [2021] HKCFI 1998, the court acknowledged a power to consider advance authorisation under section 12(7) but refused to authorise proposed payments to an overseas agency because the contemplated commercial arrangement breached section 17 of Cap. 561. Advance payment approval must therefore not be presented as a way to legalise prohibited brokerage.
Non-commercial arrangements: narrow conditions
Hong Kong’s permitted non-commercial model is highly constrained. Section 14 of Cap. 561 does not permit the use of gametes other than those of the commissioning couple, who must be parties to a marriage, for the surrogacy arrangement. The CHRT explains that pregnancy must result from a reproductive-technology procedure, as defined in the Ordinance. Thus a proposed donor-egg or donor-sperm surrogacy plan should not be advertised as fitting the local section 14 route. Section 15 contains general restrictions on treatment of unmarried persons, with a specific statutory exception for treatment of the woman acting as surrogate under the arrangement; that exception does not make an unmarried intending couple generally eligible for local surrogacy. A couple’s marriage or genetic link alone does not remove the licence, medical and counselling hurdles.
The Council’s Code of Practice provides further clinical safeguards. Chapter XII indicates that surrogacy is contemplated where the commissioning wife cannot carry a pregnancy to term and no other treatment is practicable. It calls for independent assessment of the surrogate’s suitability, informed consent and multidisciplinary counselling covering medical, psychological, social and legal implications. The Code also describes a minimum surrogate age of 21 and, where the surrogate is married, her husband’s consent. The exact current text and any licence-specific conditions must be checked with the Council before anyone relies on a clinic’s advice. These professional standards should be distinguished from primary statutory offences: a Code requirement may affect the grant, renewal or conditions of a licence without automatically being a separate criminal offence in the same wording. The actual CHRT Code effective 1 December 2025, paragraphs 12.3–12.10, additionally requires assessment by a registered doctor not responsible for the surrogacy procedure, specifies a counselling team including two non-attending doctors, a family-law adviser and a social worker, and addresses child-welfare assessment, records and reporting to the Council. These are verified Code provisions, not proof that any clinic currently holds surrogacy authorisation.
Licensing and actual availability
The existence of IVF clinics does not mean surrogacy is available there. Section 13 requires a relevant CHRT licence for covered reproductive-technology activities. The Council publishes centres and the treatments covered by their licences; a general treatment licence is not itself proof that surrogacy is a specified permitted service. A 2023 official legislative reply reported that none of the treatment licence holders at that date had surrogacy authorisation. An Inland Revenue Department FAQ consulted in October 2026 still says no licensed Hong Kong centre is currently authorised to provide surrogacy arrangements. That assertion describes the position shown by official material at the check date, not a guarantee for all future dates. Verify the current licence scope directly with CHRT, not with marketing materials alone. Section 19 of Cap. 561 expressly prevents any licence from authorising conduct contrary to sections 14–17. A clinic's licence would therefore never override the donated-gamete, treatment, commercial dealing or surrogacy-intermediation prohibitions.
Contracts, offences and legal consequences
Section 18 of Cap. 561 provides that no surrogacy arrangement is enforceable by or against the persons making it. This is not the same proposition as saying the child has no legal protection, nor does it by itself decide criminal liability or later legal parentage. Parties cannot assume a court will compel the surrogate to hand over the child, compel intended parents to take the child, or enforce a promise simply because an agreement was notarised abroad. Legal safeguards instead require informed consent, independent advice, careful clinical practice and realistic planning for disagreement, pregnancy complications or a change of intention. A signed contract is evidence of intentions and transactions, but it is not an enforceable transfer of parental status. No private clause can replace a Hong Kong parental order where that order is required.
Contravention of section 17, among other listed prohibitions, is an offence under section 39 of Cap. 561. Section 39 states that a first conviction may attract a level 4 fine and imprisonment for 6 months; a subsequent conviction may attract a level 6 fine and imprisonment for 2 years. These are statutory maximum penalty categories, not automatic sentences, and the amount corresponding to a fine level can change by general legislation. Not every payment in a family’s records proves an offence: the act, purpose, statutory exclusions, evidence and any relevant defences matter. Conversely, an absence of prosecution, a foreign clinic’s representation, or a later parental order should not be treated as advance clearance for prohibited commercial conduct. If a payment or advertisement has already happened, seek independent Hong Kong criminal and family-law advice before further steps.
Parentage is a separate legal question
Hong Kong’s parentage rules are separate from the commercial-surrogacy ban. Under section 9 of Cap. 429, the woman who carries a child following the relevant embryo or gamete treatment is ordinarily regarded as the legal mother, even if the intended mother supplied an egg. Section 10 can attribute fatherhood to a husband or male treatment partner under defined consent and treatment conditions. Biology, the agreement, a foreign birth certificate and the identity of the carers may therefore point in different directions. Avoid the opposing oversimplifications that the intended couple automatically becomes the legal parents at birth, or that an irregular programme makes the child “illegal”. Legal parentage must be established through the applicable status rules and, where available, a court process designed for the child’s welfare.
Section 12 of Cap. 429 permits a court to make a parental order in favour of parties to a marriage where a child was carried by another woman following the relevant treatment and gametes of the husband, the wife or both were used. Additional conditions include a joint application normally within 6 months of birth; the child living with one or both applicants at application and order dates; and at least one applicant being domiciled in Hong Kong, habitually resident there for the immediately preceding 1 year, or having a substantial Hong Kong connection. Both applicants must be at least 18 when the order is made. The necessary consent of the surrogate and any other legally relevant father must generally be free, fully informed and unconditional; a surrogate’s consent within 6 weeks after birth is ineffective. Section 12(7) regulates relevant payments and allows judicial approval in specified circumstances. All these issues must be assessed on facts; no parental order is automatic. Section 12(6) dispenses with the consent of a person who cannot be found or is incapable of consenting; it does not generally dispense with consent merely because the person refuses. Whether an exception applies requires evidence and judicial assessment.
Cross-border situations and practical risks
The section 14 treatment rule and section 12 parental-order rule have different functions. The first addresses what reproductive material may be used in a surrogacy procedure governed by Cap. 561; the second includes the condition that at least one intended spouse’s gametes contributed to creation of the embryo. It would be a serious error to read the broader wording of a potential parental order as approval to run a donor-gamete surrogacy service locally. Overseas conception also raises the place-of-treatment law, the nationality and status of the child, documentary recognition and potentially Hong Kong rules on paid brokering. The government’s statement that Hong Kong does not regulate the provision of reproductive procedures by an overseas institution does not establish that every Hong Kong-connected commercial negotiation or later Hong Kong parentage issue is outside its legislation.
The six-month statutory filing rule must be taken seriously, but litigation has shown that delay is not invariably fatal. In FH & MH v WB & HB [2019] HKCFI 1748, the court considered the welfare of children and permitted a late application, and scrutinised disputed payments. Such a ruling is judicial interpretation on particular facts, not a pre-approved extension for anyone who misses a deadline. A court may require evidence of why a filing was late, the legality of the foreign arrangement, actual payments, the surrogate’s position and the child’s situation. Equally, a foreign judgment or certificate identifying intended parents cannot simply be assumed to replace the Hong Kong status determination. Start court advice and evidence collection before the birth where possible; if the child is already born, act promptly without assuming either hopelessness or guaranteed relief.
Evidence and a safe decision sequence
Consider two distinct scenarios. In the first, a married couple proposes a locally performed, no-profit surrogacy procedure using both spouses’ gametes, with clinical assessment and genuine medical-expense reimbursements. Those facts may be consistent with the narrow legislative model, yet without a CHRT licence expressly covering surrogacy, it cannot simply proceed at a local IVF centre. In the second, a Hong Kong-connected couple pays a foreign agency to recruit and match a surrogate and plans to rely only on an overseas birth certificate. The fact that another country permits the arrangement does not eliminate the need to assess section 17 brokerage risks, document all payments, determine the child’s status and consider section 12 proceedings. Neither scenario is a legal opinion on a specific case; it identifies the factual changes that matter.
Before signing or paying, create a single evidence file: marriage documents; identity and residence or domicile history; clinical records explaining inability to carry a pregnancy and alternative treatments; records showing whose gametes made the embryo; the clinic’s current written licence scope; the surrogate’s independent medical assessment and informed consents; drafts of advertisements, introductions and contracts; a complete ledger of proposed fees, recipients, invoices and medical expenses; and advice about both the treatment-country law and Hong Kong law. If conception or delivery is overseas, also plan to obtain medical/birth records, the child’s proposed living arrangements, the surrogate’s and relevant father’s post-birth consents, any foreign order, translations and authentication where needed. The exact documents required by the court or another state cannot be conclusively listed without the facts and applicable procedure.
Conclusion and review limits
A safe sequence is: first check whether the intended process fits the statutory definitions, marriage and gamete requirements; next screen every proposed service, advertisement and payment for sections 16–17 risks; then obtain written confirmation of the relevant CHRT licence and current Code standards; only after independent advice examine consent and contingency plans. In parallel map legal parentage, the ordinary 6-month filing window, the parties’ Hong Kong connection and any foreign recognition questions. If no authorised local surrogacy provider exists, do not treat “non-commercial is permitted” as authority to carry it out. The supported conclusion is limited but clear: commercial organising and related promotion are prohibited, non-commercial arrangements face strict restrictions, agreements are unenforceable, and parentage requires separate analysis.
Sources and verification links
- CHRT patient FAQ, surrogacy and parenthood (S1)
- Hong Kong Government Legislative Council reply, 24 May 2023 (S2)
- CHRT Code of Practice publication and effective version (S3)
- Inland Revenue Department FAQ on assisted reproductive services (S4)
- Parent and Child Ordinance (Cap. 429), legal text reproduction (S5)
- Human Reproductive Technology Ordinance (Cap. 561), legal text reproduction (S6)
- University of Hong Kong case commentary on FH & MH v WB (S7)
- CHRT official licensed treatment centres and service matrix (S8)
- Community Legal Information Centre, prohibited acts (S9)
- Barristers case note on cross-border parental orders (S10)
- LH v LW [2021] HKCFI 1998, Hong Kong Lawyer case note (S11)








